Bruce Johnson - Publications

Affiliations: 
Pathology University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Neuropathology

68 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Iasella CJ, Snyder M, Popescu I, Wei J, Hoji A, Zhang Y, Xu W, Iouchmanov V, Brown M, Lendermon E, Johnson B, Kilaru S, Morrell M, Pilewski J, Greenland J, et al. Transcriptome Analysis of Airway Brushes in Lung Transplant Recipients with and without Chronic Lung Allograft Dysfunction. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 39: S57-S58. PMID 32465981 DOI: 10.1016/J.Healun.2020.01.1247  0.401
2020 Popescu I, Iasella C, Lendermon E, Sembrat J, Saul M, Chen X, Seyed N, Gonsallus B, Koshy R, Hannan S, Zhang Y, Xu W, Iouchmanov V, Brown M, Snyder M, ... Johnson B, et al. Persistence of Increased Type-1 Alloeffector CD4 T Cell Responses from ACR into CLAD in Lung Transplant Recipients. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 39: S165. PMID 32464961 DOI: 10.1016/J.Healun.2020.01.1120  0.406
2019 Araki T, Dahlberg SE, Hida T, Lydon CA, Rabin MS, Hatabu H, Johnson BE, Nishino M. Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome. European Journal of Radiology Open. 6: 128-131. PMID 30984804 DOI: 10.1016/j.ejro.2019.03.003  0.301
2019 Nayyar N, Shih D, Bihun I, Dagogo-Jack I, Gill C, Aquilanti E, Bertalan M, Kaplan A, D’Andrea M, Chukwueke U, Ippen F, Alvarez-Breckenridge C, Camarda N, Lastrapes M, McCabe D, ... ... Johnson B, et al. Gene-63. Genomic Characterization Of Human Brain Metastases Identifies Novel Drivers Of Lung Adenocarcinoma Progression Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.465  0.318
2019 Paz-Ares L, Garon EB, Ardizzoni A, Barlesi F, Cho BC, Junior GdC, Marchi PD, Felip E, Goto Y, Greystoke A, Lu S, Lim DW, Papadimitrakopoulou VA, Reck M, Solomon BJ, ... ... Johnson B, et al. CANOPY phase III program: Three studies evaluating canakinumab in patients with non-small cell lung cancer (NSCLC) Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz260.109  0.385
2019 Oezkan F, He K, Owen D, Pietrzak M, Cho JH, Kitzler R, Pearson R, Rusch V, Chaft J, Suh R, Blasberg J, Reckamp K, Raz D, Kneuertz P, Fiorillo L, ... ... Johnson B, et al. OA13.07 Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3 Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.482  0.309
2019 Popescu I, Iasella C, Lendermon E, Winters S, Sembrat J, Saul M, Chen X, Seyed N, Hewitt B, Koshy R, Zhang Y, Xu W, Iouchmanov V, Brown M, Johnson B, et al. Characterization of Donor-Specific Alloreactive CD4+ and CD8+ Cellular Immune T Cell Responses in the Lung Allograft and Blood in Lung Transplant Recipients Journal of Heart and Lung Transplantation. 38. DOI: 10.1016/J.Healun.2019.01.613  0.347
2018 Rusch VW, Chaft JE, Johnson B, Wistuba II, Kris MG, Lee JM, Bunn PA, Kwiatkowski DJ, Reckamp KL, Finley DJ, Haura EB, Waqar SN, Doebele RC, Garon EB, Blasberg J, et al. Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Initial results from a multicenter study (LCMC3). Journal of Clinical Oncology. 36: 8541-8541. DOI: 10.1200/Jco.2018.36.15_Suppl.8541  0.375
2018 Park H, Lydon C, Araki T, Hatabu H, Rabin M, Johnson B, Nishino M. MA25.09 M1b Disease in the 8th Edition of IASLC Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcom Journal of Thoracic Oncology. 13. DOI: 10.1016/J.Jtho.2018.08.535  0.335
2018 Rusch V, Chaft J, Johnson B, Wistuba I, Kris M, Lee J, Bunn P, Kwiatkowski D, Reckamp K, Finley D, Haura E, Waqar S, Doebele R, Garon E, Blasberg J, et al. MA04.09 Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Multicenter Study (LCMC3) Journal of Thoracic Oncology. 13. DOI: 10.1016/J.Jtho.2018.08.346  0.391
2017 Planchard D, Smit EF, Groen HJM, Mazieres J, Besse B, Helland A, Giannone V, D'Amelio A, Zhang P, Mookerjee B, Johnson B. Phase 2 trial (BRF113928) of dabrafenib (D) plus trametinib (T) in patients (pts) with previously untreated BRAF V600E-mutant metastatic non-small cell lung cancer (NSCLC) Annals of Oncology. 28. DOI: 10.1093/Annonc/Mdx440.054  0.383
2017 Kris M, Aisner D, Sholl L, Berry L, Rossi M, Chen H, Fujimoto J, Moreira A, Ramalingam S, Villaruz L, Otterson G, Haura E, Politi K, Glisson B, Cetnar J, ... ... Johnson B, et al. P3.03-007 LCMC2: Expanded Profiling of Lung Adenocarcinomas Identifies ROS1 and RET Rearrangements and TP53 Mutations as a Negative Prognostic Factor Journal of Thoracic Oncology. 12: S2275. DOI: 10.1016/J.Jtho.2017.09.1633  0.338
2017 Owen D, Bunn P, Johnson B, Kwiatkowski D, Kris M, Wistuba I, Gandhi M, Phan S, Shames D, Schulze K, Bernaards C, Aisner D, Chaft J, Gainor J, Lee J, et al. P2.06-019 A Phase II Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Patients (pts) with Resectable Non-Small Cell Lung Cancer (NSCLC): Topic: Phase II + NK Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2016.11.1512  0.361
2017 Behnia M, Avolio A, Johnson B. Influence of Dietary Nitrate Supplementation on Lung Function and Exercise Gas Exchange in COPD Patients Chest. 152. DOI: 10.1016/J.Chest.2017.08.822  0.316
2015 Crespo MM, Bermudez CA, Dew MA, Johnson BA, George MP, Bhama J, Morrell M, D'Cunha J, Shigemura N, Richards TJ, Pilewski JM. Lung Transplantation in Patients with Scleroderma Compared with Pulmonary Fibrosis: Short and Long-term Outcomes in a Single Institution. Annals of the American Thoracic Society. PMID 26669584 DOI: 10.1513/AnnalsATS.201503-177OC  0.306
2014 Morrell MR, Gries C, Crespo M, Johnson B, Hayanga A, Bhama J, Shigemura N, Bermudez C, Pilewski J. Lung Transplantation in Recipients >70 Years Old: A Single Center Experience Journal of Heart and Lung Transplantation. 33. DOI: 10.1016/J.Healun.2014.01.370  0.379
2013 Shigemura N, Sclabassi RJ, Bhama JK, Gries CJ, Crespo MM, Johnson B, Pilewski JM, Bermudez CA. Early major neurologic complications after lung transplantation: incidence, risk factors, and outcome. Transplantation. 95: 866-71. PMID 23354301 DOI: 10.1097/Tp.0B013E318280B359  0.394
2013 Shigemura N, Toyoda Y, Bhama JK, Gries CJ, Crespo M, Johnson B, Zaldonis D, Pilewski JM, Bermudez CA. Donor smoking history and age in lung transplantation: a revisit. Transplantation. 95: 513-518. PMID 23202531 DOI: 10.1097/Tp.0B013E3182751F1F  0.352
2013 Timofte I, Crespo M, Bermudez C, D'Cunha J, Bhama J, Shigemura N, Johnson B. Addition of Rapamycin to the Immunosuppressant Regimen Improves Airway Patency in Lung Transplant Patients With Refractory Bronchial Stenosis Chest. 144. DOI: 10.1378/Chest.1703797  0.414
2013 Shigemura N, D’Cunha J, Hackman A, Ela AAE, Shiose A, Bhama J, Gries C, Crespo M, Zaldonis D, Johnson B, Pilewski J, Bermudez C. Lobar Lung Transplantation for High Risk Patients – Lessons from the Initial Experience Journal of Heart and Lung Transplantation. 32. DOI: 10.1016/J.Healun.2013.01.966  0.391
2012 Shigemura N, Bhama J, Gries CJ, Kawamura T, Crespo M, Johnson B, Zaldonis D, Pilewski J, Toyoda Y, Bermudez C. Lung Transplantation in Patients With Prior Cardiothoracic Surgical Procedures American Journal of Transplantation. 12: 1249-1255. PMID 22300103 DOI: 10.1111/J.1600-6143.2011.03946.X  0.355
2012 Shigemura N, Bhama J, Fujimoto K, Shiose A, Ali A, Kanemitsu H, Gries C, Crespo M, Johnson B, Pilewski J, Bermudez C. 730 Early Major Neurologic Complications after Lung Transplantation: Prevalence, Risk Factors and Outcome Journal of Heart and Lung Transplantation. 31. DOI: 10.1016/J.Healun.2012.01.746  0.363
2012 Crespo MM, Clancy CJ, Pilewski JM, Bermudez C, Jarido V, Johnson B, Haider SS, Bhama J, Toyoda Y, Morrell M, Shigemura N, Nguyen MH. 724 Primary Graft Dysfunction (PGD) vs Transfusion-Related Lung Injury (TRLI) in Lung Transplantation (LT): Can These Entities Be Differentiated Based on the Current ISHLT PGD Definition? Journal of Heart and Lung Transplantation. 31. DOI: 10.1016/J.Healun.2012.01.740  0.39
2012 Nguyen MH, Clancy CJ, Crespo MM, Pilewski J, Bermudez C, Shigemura N, Bhama JK, Johnson B, Morrell M, Shields RK, Kwak EJ, Silveira F, Toyoda Y. 281 Alemtuzumab (Amab) vs. Basiliximab (Bmab) Induction: Impact on Infectious and Non-Infectious Outcomes among Lung Transplant Patients (LT pts) Journal of Heart and Lung Transplantation. 31. DOI: 10.1016/J.Healun.2012.01.289  0.395
2012 Crespo MM, Zaldonis D, Bermudez C, Johnson B, Haider S, Morrell M, Bhama J, Toyoda Y, Shigemura N, George P, Pilewski JM. 83 Lung Transplantation in Patients with Scleroderma: Long-Term Follow Up and Risk Factors for Poor Survival Journal of Heart and Lung Transplantation. 31. DOI: 10.1016/J.Healun.2012.01.087  0.377
2011 Shigemura N, Sareyyupoglu B, Bhama J, Bonde P, Thacker J, Bermudez C, Gries C, Crespo M, Johnson B, Pilewski J, Toyoda Y. Combining tricuspid valve repair with double lung transplantation in patients with severe pulmonary hypertension, tricuspid regurgitation, and right ventricular dysfunction. Chest. 140: 1033-9. PMID 21700686 DOI: 10.1378/Chest.10-2929  0.357
2011 Shigemura N, Gilbert S, Bhama J, Bansal A, Bonde P, Bermudez C, Gries C, Crespo M, Johnson B, Pilewski J, Luketich J, Toyoda Y. Risk-Benefit Tradeoffs in Lung Volume Reduction Surgery as a Bridge to Lung Transplantation for End-Stage Emphysema Chest. 140. DOI: 10.1378/Chest.1118056  0.394
2011 Shigemura N, Bhama J, Bonde P, Thacker J, Bermudez C, Sareyyupoglu B, Bansal A, Minakata K, Shayan H, Ohta T, Fujimoto K, Crespo M, Johnson B, Pilewski J, Toyoda Y. 315 Donors with Smoking History Have Better Long-Term Outcomes Than with No Smoking History in Adult Lung Transplantation Journal of Heart and Lung Transplantation. 30. DOI: 10.1016/J.Healun.2011.01.322  0.305
2011 Golden JA, Dilly SG, Breen TJ, Johnson B. 203 The Influence of Induction Regimen on the Early Incidence of Biopsy-Determined Acute Rejection in Lung Transplant Patients Journal of Heart and Lung Transplantation. 30. DOI: 10.1016/J.Healun.2011.01.210  0.398
2011 Morrell MR, Spichty K, Gries CJ, Crespo MM, Johnson B, Pilewski JM, Toyoda Y, Bermudez CA, Bhama JK, Zaldonis D, Zeevi A. 84 The Impact of Donor Specific HLA Antibodies in Lung Transplantation after Induction with Alemtuzumab Journal of Heart and Lung Transplantation. 30. DOI: 10.1016/J.Healun.2011.01.091  0.395
2010 Husain S, Capitano B, Corcoran T, Studer SM, Crespo M, Johnson B, Pilewski JM, Shutt K, Pakstis DL, Zhang S, Carey ME, Paterson DL, McCurry KR, Venkataramanan R. Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients. Transplantation. 90: 1215-9. PMID 20881664 DOI: 10.1097/Tp.0B013E3181F995Ea  0.371
2010 Shigemura N, Bermudez C, Hattler BG, Johnson B, Crespo M, Pilewski J, Toyoda Y. Lung transplantation for pulmonary alveolar microlithiasis. The Journal of Thoracic and Cardiovascular Surgery. 139. PMID 19660326 DOI: 10.1016/J.Jtcvs.2008.07.066  0.401
2010 Shigemura N, Brann S, Wasson S, Bhama J, Bermudez C, Hattler BG, Johnson B, Crespo M, Pilewski J, Toyoda Y. Successful lung transplantation in an octogenarian. The Journal of Thoracic and Cardiovascular Surgery. 139: e47-8. PMID 19660321 DOI: 10.1016/J.Jtcvs.2008.06.044  0.347
2010 Groves S, Galazka M, Johnson B, Corcoran T, Verceles A, Britt E, Todd N, Griffith B, Smaldone GC, Iacono A. Inhaled cyclosporine and pulmonary function in lung transplant recipients. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23: 31-9. PMID 19580368 DOI: 10.1089/Jamp.2009.0748  0.395
2010 Shigemura N, Bhama J, Thacker J, Bermudez C, Pilewski J, Johnson B, Crespo M, Toyoda Y. Lung Transplantation for Patients With Prior Cardiothoracic Surgical Procedures Chest. 138. DOI: 10.1378/Chest.10651  0.389
2010 Shigemura N, Sareyyupoglu B, Tabata S, Horai T, Bonde P, Crespo M, Johnson B, Pilewski J, Bhama J, Gilbert S, Bermudez C, Toyoda Y. 428: Initial Experience with Concomitant Surgery of Lung Transplantation and Tricuspid Valve Repair for Patients with Severe Pulmonary Hypertension Journal of Heart and Lung Transplantation. 29. DOI: 10.1016/J.Healun.2009.11.443  0.367
2010 Crespo MM, Zaldonis D, George MP, Toyoda Y, Johnson B, Bermudez C, Haider SS, Bhama JK, Morell MR, Pilewski JM. 337: Lung Transplantation in Patients with Scleroderma: A Single Center Experience Journal of Heart and Lung Transplantation. 29. DOI: 10.1016/J.Healun.2009.11.350  0.41
2010 Horai T, Shigemura N, Bonde P, Sareyyupoglu B, Tabata S, Pilewski J, Crespo M, Johnson B, George P, Morrell M, Kormos RL, Bhama JK, Gilbert S, Bermudez CA, Toyoda Y. 116: Lung Transplantation with Lungs from Donors 55 Years or Older Journal of Heart and Lung Transplantation. 29. DOI: 10.1016/J.Healun.2009.11.125  0.407
2009 Shigemura N, Bermudez C, Hattler BG, Johnson B, Crespo M, Pilewski J, Toyoda Y. Impact of Graft Volume Reduction for Oversized Grafts After Lung Transplantation on Outcome in Recipients With End-stage Restrictive Pulmonary Diseases Journal of Heart and Lung Transplantation. 28: 130-134. PMID 19201337 DOI: 10.1016/J.Healun.2008.11.003  0.391
2009 Johnson B, Miller V, Amler L, Stern H, Soh C, O'Connor P, Kabbinavar F. 8LBA Biomarker evaluation in the randomized, double-blind, placebo-controlled, Phase IIIb ATLAS Trial, comparing bevacizumab (B) therapy with or without erlotinib (E), after completion of chemotherapy with B for the treatment of locally-advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC) Ejc Supplements. 7: 5-6. DOI: 10.1016/S1359-6349(09)72037-3  0.346
2009 Soria JC, Bennouna J, Leighl N, Khuri F, Traynor AM, Johnson B, Kay A, Blais N, Jehl V, Papadimitrakopoulou V. 9174 Phase II study of everolimus plus erlotinib in previously treated patients with advanced non-small cell lung cancer (NSCLC) Ejc Supplements. 7: 558-559. DOI: 10.1016/S1359-6349(09)71887-7  0.405
2009 Toyoda Y, Zaldonis D, Bermudez C, Speziali G, Gilbert S, Bhama J, Johnson B, Crespo M, Pilewski J. 204: 20-Year Experience of Lung Transplantation for Chronic Obstructive Pulmonary Disease Journal of Heart and Lung Transplantation. 28. DOI: 10.1016/J.Healun.2008.11.834  0.366
2009 Bermudez C, Girnita A, Avila F, Zeevi A, Crespo M, Pilewski J, Speziali G, Johnson B, Zaldonis D, Toyoda Y. 200: Clinical Experience with the Use of Virtual Crossmatch in Adult Lung Transplantation Journal of Heart and Lung Transplantation. 28. DOI: 10.1016/J.Healun.2008.11.830  0.37
2009 Garcia-Covarrubias L, Toyoda Y, Crespo M, Pilewski J, Johnson B, Bhama JK, Bermudez CA. 625: Impact of Coronary Artery Disease in Lung Transplant Patients. A Single Center Experience Journal of Heart and Lung Transplantation. 28. DOI: 10.1016/J.Healun.2008.11.632  0.344
2009 Toyoda Y, Bermudez C, Speziali G, Gilbert S, Bhama J, Gongora E, Garcia L, Zenati M, Zomak R, Zaldonis D, Johnson B, Crespo M, Pilewski J. 555: Older Donor for Older Recipient in Lung Transplantation Journal of Heart and Lung Transplantation. 28. DOI: 10.1016/J.Healun.2008.11.562  0.356
2008 Toyoda Y, Thacker J, Santos R, Nguyen D, Bhama J, Bermudez C, Kormos R, Johnson B, Crespo M, Pilewski J, Teuteberg J, Alvarez R, Mathier M, McNamara D, McCurry K, et al. Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension. The Annals of Thoracic Surgery. 86: 1116-22. PMID 18805144 DOI: 10.1016/J.Athoracsur.2008.05.049  0.405
2007 Husain S, Paterson DL, Studer SM, Crespo M, Pilewski J, Durkin M, Wheat JL, Johnson B, McLaughlin L, Bentsen C, McCurry KR, Singh N. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation. 83: 1330-6. PMID 17519782 DOI: 10.1097/01.Tp.0000263992.41003.33  0.389
2007 Crespo MM, Johnson BA, McCurry KR, Landreneau RJ, Sciurba FC. Use of endobronchial valves for native lung hyperinflation associated with respiratory failure in a single-lung transplant recipient for emphysema. Chest. 131: 214-6. PMID 17218578 DOI: 10.1378/chest.06-1171  0.312
2007 Crespo MM, Pilewski JM, Johnson B, Studer SM, McCurry KM, Husain S. Prospective Assessment Of Diagnostic Utility Of Different Bronchoscopy Sampling Modalities For Bacterial Pneumonia In Lung Transplant Recipients Chest. 132. DOI: 10.1378/Chest.132.4_Meetingabstracts.594B  0.372
2007 Raza K, Studer S, Paterson DL, Pilewski J, Johnson B, Crespo M, Silveira F, Pakstis DL, Shutt K, Husain S, McCurry KR. Infectious complications at one year in lung retransplant recipients (LRTRs): A matcbed case control study American Journal of Transplantation. 7: 504-504. DOI: 10.1111/J.1600-6143.2007.01811.X  0.366
2006 Husain S, Paterson DL, Studer S, Pilewski J, Crespo M, Zaldonis D, Shutt K, Pakstis DL, Zeevi A, Johnson B, Kwak EJ, McCurry KR. Voriconazole prophylaxis in lung transplant recipients American Journal of Transplantation. 6: 3008-3016. PMID 17062003 DOI: 10.1111/J.1600-6143.2006.01548.X  0.387
2005 McCurry KR, Iacono A, Zeevi A, Yousem S, Girnita A, Husain S, Zaldonis D, Johnson B, Hattler BG, Starzl TE. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy Journal of Thoracic and Cardiovascular Surgery. 130: 528-537. PMID 16077423 DOI: 10.1016/J.Jtcvs.2004.09.040  0.409
2005 Girnita AL, Duquesnoy R, Yousem SA, Iacono AT, Corcoran TE, Buzoianu M, Johnson B, Spichty KJ, Dauber JH, Burckart G, Griffith BP, McCurry KR, Zeevi A. HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 5: 131-8. PMID 15636621 DOI: 10.1111/J.1600-6143.2004.00650.X  0.338
2005 Engelman J, Janne P, Mermel C, Pearlberg J, Mukohara T, Fleet C, Cichowski K, Johnson B, Cantley L. PD-142 ErbB-3 mediates PI3K activity in gefitinib-sensitive non-smallcell lung cancer cell lines Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80475-1  0.334
2005 Jackman D, Lucca J, Fidias P, Rabin M, Lynch T, Ostler P, Skarin A, Temel J, Johnson B, Janne P. O-188 Phase II study of the EGFR tyrosine kinase inhibitor erlotinib (Tarceva) in patients >70 years of age with previously untreated advanced non-small cell lung carcinoma Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80322-8  0.345
2005 Herbst R, Davies A, Johnson B, Natale R, Dang T, Murren J, Schiller J, Garland L, Miller V, Mendelson D, Melenevsky Y, Devries D, Abbeele AVD, Eberhard D, Lyons B, et al. O-187 Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in Non-Small Cell Lung Cancer (NSCLC) patients after prior chemotherapy Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80321-6  0.361
2005 Mukohara T, Engelman J, Lindeman N, Pearlberg J, Cantley L, Johnson B, Jänne P. O-009 Differential effects of gefitinib and cetuximab on EGFR mutant non-small cell lung cancers (NSCLC) cell lines Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80141-2  0.359
2004 Herbst RS, Prager D, Hermann R, Miller V, Fehrenbacher L, Hoffman P, Johnson B, Sandler AB, Mass R, Johnson DH. TRIBUTE - A phase III trial of erlotinib HCl (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 7011. PMID 28016269 DOI: 10.1200/Jco.2004.22.14_Suppl.7011  0.366
2004 Miller VA, Herbst R, Prager D, Fehrenbacher L, Hermann R, Hoffman P, Johnson B, Sandler AB, Kris MG, Ramies D. Long survival of never smoking non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib HCl (OSI-774) and chemotherapy: Sub-group analysis of TRIBUTE. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 7061. PMID 28016112 DOI: 10.1200/Jco.2004.22.14_Suppl.7061  0.347
2004 Girnita AL, Iacono AT, Corcoran TE, Yousem SA, Duquesnoy R, Johnson B, Dauber JH, Spichty KJ, Griffith BP, McCurry KR, Zeevi A. De novo HLA antibodies and lymphocytic bronchiolitis are significantly correlated with bronchiolitis obliterans syndrome in lung transplantation Journal of Heart and Lung Transplantation. 23. DOI: 10.1016/J.Healun.2003.11.008  0.362
2003 Cross CK, Berman S, Buswell L, Johnson B, Baldini EH. A prospective study of palliative hypofractionated radiation Therapy (8.5Gy × 2) for patients with symptomatic non-small cell lung cancer International Journal of Radiation Oncology Biology Physics. 58: 1098-1105. PMID 15001250 DOI: 10.1016/J.Ijrobp.2003.08.005  0.357
2000 Fidias P, Supko J, Martins R, Boral A, Skarin A, Johnson B, Carey R, Grossbard M, Vasconcelles M, Shapiro G, Lynch TJ. A phase II clinical and pharmacokinetic study of weekly paclitaxel in elderly patients with non-small cell lung cancer Lung Cancer. 29: 57. DOI: 10.1016/S0169-5002(00)80184-1  0.39
1995 Moscow JA, Schmidt L, Ingram DT, Gnarra J, Johnson B, Cowan KH. Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer. Carcinogenesis. 15: 2769-73. PMID 8001233 DOI: 10.1093/Carcin/15.12.2769  0.344
1994 Bunn P, Arriagada R, Choi N, Feld R, Gregor A, Jett J, Johnson B, Komaki R, Kristjansen P, Murray N, Ohnoshi T, Perry M, Quoix E, Saijo N, Shaw E. Combined modality therapy in small cell lung cancer Lung Cancer. 10. PMID 8087517 DOI: 10.1016/0169-5002(94)91664-0  0.34
1993 D'Amico D, Carbone D, Johnson B, Meltzer S, Minna J. Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer Lung Cancer. 8: 337. DOI: 10.1016/0169-5002(93)90534-5  0.343
1990 Brauch H, Tory K, Kotler F, Gazdar AF, Pettengill OS, Johnson B, Graziano S, Winton T, Buys CHCM, Sorenson GD, Poiesz BJ, Minna JD, Zbar B. Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer. Genes, Chromosomes and Cancer. 1: 240-246. PMID 1982064 DOI: 10.1002/Gcc.2870010309  0.315
1989 Feld R, Abeloff MD, Ball DL, Drings P, Gregor A, Johnson B, Maasilta P, Saijo N, Sörenson S, van Zandwijk N. Toxicity and supportive care in small cell lung cancer: a consensus report Lung Cancer. 5: 146-151. DOI: 10.1016/0169-5002(89)90162-1  0.303
1987 Brauch H, Johnson B, Hovis J, Yano T, Gazdar A, Pettengill OS, Graziano S, Sorenson GD, Poiesz BJ, Minna J. Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. The New England Journal of Medicine. 317: 1109-13. PMID 2821398 DOI: 10.1056/Nejm198710293171803  0.329
Show low-probability matches.